Overview

Simvastatin For Intracerebral Hemorrhage Study

Status:
Terminated
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
Study Objective: To analyze if statins are effective in ameliorating perihematomal edema evolution thereby reducing mortality and improving functional outcomes following spontaneous intracerebral hemorrhage (ICH).
Phase:
Phase 2
Details
Lead Sponsor:
Johns Hopkins University
Collaborators:
National Center for Research Resources (NCRR)
National Institutes of Health (NIH)
Treatments:
Simvastatin